Results 211 to 220 of about 1,962,441 (281)

Spiro-helicenoid Carbofluoresceins: CPL-Active Emitters for Bioimaging. [PDF]

Org Lett
Erviti-Marticorena L, Simón-Fuente S, Míguez-Lago S, Paredes JM, Ribagorda M, Girón-González MD, Millán A, Cuerva JM, Miguel D.   +8 more
europepmc   +1 more source

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar, Malede Mequanent Sisay, Leonardo Roque‐Pereira, Christine Leopold, Patrick C. Souverein, Aukje K. Mantel‐Teeuwisse, Marie L. De Bruin   +6 more
wiley   +1 more source

Bi-Assisted Double-Sided ZnO Nanorod Architectures for Fast and Geometry-Enhanced X‑Ray Scintillation. [PDF]

ACS Appl Opt Mater
Kurudirek SV, Erickson A, Sellin PJ, Lawrie BJ, Balandin TA, Stand L, Melcher CL, Azoulay JD, Hertel NE, Kurudirek M.   +9 more
europepmc   +1 more source

Glucocorticoid exposure and initiation of SSRIs among patients with rheumatoid arthritis: A nested case–control study in UK primary care

British Journal of Clinical Pharmacology, EarlyView.
Aim The immune system might affect the development of anxiety disorders, though mechanisms remain unclear. This nested case–control study investigates whether use of glucocorticoids, potent immunosuppressants, is associated with SSRI initiation (a proxy for pharmacologically treated mental disorders, predominantly depression and/or anxiety).
Elise J. Heesbeen, Patrick C. Souverein, Eibert R. Heerdink, Elisabeth Y. Bijlsma, Lucianne Groenink   +4 more
wiley   +1 more source

Pseudorabies virus pUL40 drives inflammatory signaling through competitive hijacking of EphA2 from the Akt-EphA2 interaction. [PDF]

Vet Res
Tian Y, Yin H, Fu J, Yang Q, Yan R, Li Y, Ye C, Fang R.   +7 more
europepmc   +1 more source

Histamine and the mechanisms of nausea and vomiting: Translating the uncertain pharmacology of cyclizine

British Journal of Clinical Pharmacology, EarlyView.
Abstract Cyclizine is a long‐established, short‐acting drug, registered for preventing motion sickness, post‐operative nausea and vomiting (PONV) and ‘vomiting of known cause’. The latter is not defined but may include pregnancy and patients receiving palliative care, historically accepted without large, controlled trials.
Gareth J. Sanger, Paul L. R. Andrews
wiley   +1 more source

Health Promotion and Healthspan: Phenotypic Biomarkers Catalyzing Modern Medicine. [PDF]

Oman Med J
Kuijpers W, Harper D, Alexander J.
europepmc   +1 more source

Fragmentomics features of cell free DNA in eating disorders. [PDF]

Transl Psychiatry
Burova A, Verebi C, Lebrun N, Nectoux J, Boutonnet A, Duriez P, Gorwood P, Ramoz N, Bienvenu T.   +8 more
europepmc   +1 more source

Dual‐targeted nanomedicine delivering doxorubicin and nitric oxide for tumor immunomodulation and synergistic therapy

BMEMat, EarlyView.
The mechanism of HA‐DS@PLGA nanoparticles co‐delivering DOX and SNAP (an NO donor) to suppress tumor growth, remodel the tumor microenvironment, and enhance antitumor immune responses for effective combinatorial cancer therapy. Abstract Cancer therapeutic efficacy is significantly influenced by tumor immunosuppressive environment possibly induced by ...
Xingzhou Peng, Wei Chen, Shuyu Li, Xiaomin Ma, Yanfeng Dai, Yan Wang, Changqiang Xie, Yazhe Xiao, Hesong Han, Yumiao Zhang, Junjie Wang   +10 more
wiley   +1 more source

Global phylogenomics of Bordetella pertussis ST2 reveals regional heterogeneity in China and lineage-specific genome evolution. [PDF]

BMC Genomics
Qi M, Zhou W, Ye H, Lei D, Dong X, Wu X.
europepmc   +1 more source